A
HRTX icon

AJOVista’s Heron Therapeutics HRTX Stock Holding History

AJOVista’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$44.8K Buy
22,492
+2,774
+14% +$6.62K 0.19% 101
2024
Q2 		$69K Buy
+19,718
New +$60.6K 0.2% 61

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AJOVista's HRTX Position: Q3 2024 in Review

AJOVista increased its Heron Therapeutics (HRTX) stake by 14% in Q3 2024, buying an estimated $6.62K and bringing the position to 22,492 shares worth $44.8K. The position accounts for 0.19% of the portfolio, ranked #101.

AJOVista first reported a position in HRTX in Q2 2024 and has held it in 2 quarters since. The position peaked at $69K in Q2 2024. 173 funds tracked by Wall St. Rank hold HRTX as of Q3 2024.

  • AJOVista held 22,492 shares of Heron Therapeutics worth $44.8K as of Q3 2024.
  • AJOVista bought 2,774 Heron Therapeutics shares in Q3 2024, an estimated $6.62K.
  • Heron Therapeutics made up 0.19% of AJOVista's portfolio in Q3 2024, its #101 holding.
  • AJOVista first reported a position in Heron Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • AJOVista's Heron Therapeutics position peaked at $69K in Q2 2024.
  • 173 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.